Page last updated: 2024-08-24

mk 0591 and Acute Disease

mk 0591 has been researched along with Acute Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bukhave, K; Depré, M; Friedman, BS; Hillingsø, J; Kjeldsen, J; Lauritsen, K; Laursen, LS; Malmström, K; Shingo, S; von Spreckelsen, S1
Boros, V; Burghardt, JS; Morgan, CJ; Olson, DM1

Trials

1 trial(s) available for mk 0591 and Acute Disease

ArticleYear
Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis.
    Clinical pharmacology and therapeutics, 1995, Volume: 57, Issue:3

    Topics: Acute Disease; Administration, Oral; Adult; Colitis, Ulcerative; Dinoprostone; Double-Blind Method; Female; Humans; Indoles; Leukotriene B4; Male; Middle Aged; Quinolines

1995

Other Studies

1 other study(ies) available for mk 0591 and Acute Disease

ArticleYear
Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats.
    The American journal of physiology, 1997, Volume: 272, Issue:3 Pt 1

    Topics: Acute Disease; Animals; Animals, Newborn; Arachidonate 5-Lipoxygenase; Body Weight; Female; Hyperoxia; In Vitro Techniques; Indoles; Leukotrienes; Lipoxygenase Inhibitors; Lung; Lung Injury; Male; Naphthaleneacetic Acids; Pulmonary Alveoli; Quinolines; Rats; Rats, Sprague-Dawley; Time Factors

1997